{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2012-N-0002\" sorted by posted_date descending", "rows": [["FDA-2012-N-0002-0046", "FDA", "FDA-2012-N-0002", "Freedom of Information Summary ANADA 200-543 Cefpodoxime Proxetil", "Supporting & Related Material", "Freedom of Information Summary", "2013-01-28T05:00:00Z", 2013, 1, null, null, "2013-01-28T18:25:57Z", null, 0, 0, "09000064811db0ef"], ["FDA-2012-N-0002-0044", "FDA", "FDA-2012-N-0002", "Freedom of Information Summary ANADA 200-485,  Meloxicam Injection (meloxicam)", "Supporting & Related Material", "Freedom of Information Summary", "2013-01-28T05:00:00Z", 2013, 1, null, null, "2013-01-28T17:50:36Z", null, 0, 0, "09000064811db0ed"], ["FDA-2012-N-0002-0045", "FDA", "FDA-2012-N-0002", "Freedom of Information Summary ANADA 200-491,  Loxicom (meloxicam)", "Supporting & Related Material", "Reference (internal unless indicated)", "2013-01-28T05:00:00Z", 2013, 1, null, null, "2013-01-28T17:55:11Z", null, 0, 0, "09000064811db0ee"], ["FDA-2012-N-0002-0043", "FDA", "FDA-2012-N-0002", "New Animal Drugs: Cefpodoxime; Meloxicam", "Rule", "Final Rule", "2013-01-28T05:00:00Z", 2013, 1, "2013-01-28T05:00:00Z", null, "2013-01-28T17:36:55Z", "2013-01647", 0, 0, "09000064811dabb6"], ["FDA-2012-N-0002-0042", "FDA", "FDA-2012-N-0002", "Freedom of Information Summary NADA 200-496 96% Solution Growing chickens, turkeys and laying hens", "Supporting & Related Material", "Freedom of Information Summary", "2013-01-08T05:00:00Z", 2013, 1, null, null, "2013-01-08T15:58:33Z", null, 0, 0, "09000064811a296c"], ["FDA-2012-N-0002-0041", "FDA", "FDA-2012-N-0002", "Freedom of Information Summary NADA 200-534 Melengestrol acetate plus monensin USP plus tylosin phosphate", "Supporting & Related Material", "Freedom of Information Summary", "2013-01-04T05:00:00Z", 2013, 1, null, null, "2013-01-04T17:21:54Z", null, 0, 0, "09000064811a7caf"], ["FDA-2012-N-0002-0040", "FDA", "FDA-2012-N-0002", "New Animal Drugs: Meloxicam; Nicarbazin", "Rule", "Final Rule", "2013-01-02T05:00:00Z", 2013, 1, "2013-01-02T05:00:00Z", null, "2013-01-02T16:46:59Z", "2012-31234", 0, 0, "09000064811a1e82"], ["FDA-2012-N-0002-0039", "FDA", "FDA-2012-N-0002", "Freedom of Information Summary NADA 141-068 BAYTRIL 100 Injectable Solution", "Supporting & Related Material", "Reference (internal unless indicated)", "2012-12-31T05:00:00Z", 2012, 12, null, null, "2012-12-31T16:35:08Z", null, 0, 0, "09000064811a07bf"], ["FDA-2012-N-0002-0036", "FDA", "FDA-2012-N-0002", "Freedom of Information Summary ANADA 200-466 SPARMECTIN Plus Clorsulon", "Supporting & Related Material", "Freedom of Information Summary", "2012-12-31T05:00:00Z", 2012, 12, null, null, "2012-12-31T16:35:07Z", null, 0, 0, "090000648114c76f"], ["FDA-2012-N-0002-0032", "FDA", "FDA-2012-N-0002", "New Animal Drugs: Enrofloxacin; Melengestrol; Meloxicam; Pradofloxacin; Tylosin", "Rule", "Final Rule", "2012-12-31T05:00:00Z", 2012, 12, "2012-12-31T05:00:00Z", null, "2012-12-31T15:19:06Z", "2012-31397", 0, 0, "09000064811a03c6"], ["FDA-2012-N-0002-0038", "FDA", "FDA-2012-N-0002", "Freedom of Information Summary NADA 141-346 OroCAM", "Supporting & Related Material", "Freedom of Information Summary", "2012-12-31T05:00:00Z", 2012, 12, null, null, "2012-12-31T16:35:08Z", null, 0, 0, "09000064811a07bc"], ["FDA-2012-N-0002-0034", "FDA", "FDA-2012-N-0002", "Freedom of Information Summary NADA 141-340 SKYCIS 100", "Supporting & Related Material", "Freedom of Information Summary", "2012-12-31T05:00:00Z", 2012, 12, null, null, "2012-12-31T16:35:07Z", null, 0, 0, "090000648114c01f"], ["FDA-2012-N-0002-0035", "FDA", "FDA-2012-N-0002", "Freedom of Information Summary NADA 141-342 ALFAXAN", "Supporting & Related Material", "Freedom of Information Summary", "2012-12-31T05:00:00Z", 2012, 12, null, null, "2012-12-31T16:35:07Z", null, 0, 0, "090000648114c76d"], ["FDA-2012-N-0002-0033", "FDA", "FDA-2012-N-0002", "Freedom of Information Summary NADA 141-339 OVUGEL", "Supporting & Related Material", "Freedom of Information Summary", "2012-12-31T05:00:00Z", 2012, 12, null, null, "2012-12-31T16:35:07Z", null, 0, 0, "090000648114c01d"], ["FDA-2012-N-0002-0037", "FDA", "FDA-2012-N-0002", "Freedom of Information Summary NADA 141-344 VERAFLOX Suspension for Cats", "Supporting & Related Material", "Freedom of Information Summary", "2012-12-31T05:00:00Z", 2012, 12, null, null, "2012-12-31T16:35:08Z", null, 0, 0, "09000064811a07b7"], ["FDA-2012-N-0002-0031", "FDA", "FDA-2012-N-0002", "New Animal Drugs; Approvals; Changes of Sponsor; Change of Sponsor's Name; Change of Sponsor's Address: Alfaxalone; Ivermectin and Clorsulon; Narasin; Triptorelin", "Rule", "Final Rule", "2012-10-23T04:00:00Z", 2012, 10, "2012-10-23T04:00:00Z", null, "2012-10-23T13:10:53Z", "2012-25989", 0, 0, "090000648114c4e5"], ["FDA-2012-N-0002-0029", "FDA", "FDA-2012-N-0002", "Freedom of Information Summary NADA 141-277 Spinosad", "Supporting & Related Material", "Freedom of Information Summary", "2012-10-09T04:00:00Z", 2012, 10, null, null, "2012-10-09T16:25:17Z", null, 0, 0, "0900006481138f8f"], ["FDA-2012-N-0002-0030", "FDA", "FDA-2012-N-0002", "Freedom of Information Summary NADA 141-343 Tilmicosin Phosphate and Monensin", "Supporting & Related Material", "Freedom of Information Summary", "2012-10-09T04:00:00Z", 2012, 10, null, null, "2012-10-09T16:35:53Z", null, 0, 0, "0900006481138f91"], ["FDA-2012-N-0002-0028", "FDA", "FDA-2012-N-0002", "New Animal Drugs: Change of Sponsor's Address; Monensin; Spinosad; Tilmicosin", "Rule", "Final Rule", "2012-10-04T04:00:00Z", 2012, 10, "2012-10-04T04:00:00Z", null, "2012-10-04T13:06:07Z", "2012-24475", 0, 0, "0900006481133f57"], ["FDA-2012-N-0002-0027", "FDA", "FDA-2012-N-0002", "New Animal Drugs: Butorphanol; Doxapram; Triamcinolone; Tylosin", "Rule", "Final Rule", "2012-10-03T04:00:00Z", 2012, 10, "2012-10-03T04:00:00Z", "2012-10-16T03:59:59Z", "2012-10-03T14:49:23Z", "2012-24331", 0, 0, "09000064811328d5"], ["FDA-2012-N-0002-0026", "FDA", "FDA-2012-N-0002", "New Animal Drugs for Use in Animal Feeds: Monensin", "Rule", "Final Rule", "2012-09-19T04:00:00Z", 2012, 9, "2012-09-19T04:00:00Z", null, "2012-09-19T13:25:22Z", "2012-23065", 0, 0, "090000648111dfc3"], ["FDA-2012-N-0002-0025", "FDA", "FDA-2012-N-0002", "New Animal Drugs: Change of Sponsor; Change of Sponsor Address; Lincomycin and Spectinomycin Soluble Powder; Sulfadimethoxine Oral Solution and Soluble Powder; Tiamulin", "Rule", "Final Rule", "2012-09-14T04:00:00Z", 2012, 9, "2012-09-14T04:00:00Z", null, "2012-09-14T13:58:39Z", "2012-22646", 0, 0, "090000648111719b"], ["FDA-2012-N-0002-0024", "FDA", "FDA-2012-N-0002", "New Animal Drugs: Enrofloxacin; Tylvalosin", "Rule", "Final Rule", "2012-09-10T04:00:00Z", 2012, 9, "2012-09-10T04:00:00Z", null, "2012-09-10T21:46:26Z", "2012-22194", 0, 0, "090000648110ec30"], ["FDA-2012-N-0002-0021", "FDA", "FDA-2012-N-0002", "Freedom of Information Summary NADA 141-326 Cephalexin", "Supporting & Related Material", "Freedom of Information Summary", "2012-08-09T04:00:00Z", 2012, 8, null, null, "2012-08-09T14:38:19Z", null, 0, 0, "09000064810ca980"], ["FDA-2012-N-0002-0020", "FDA", "FDA-2012-N-0002", "New Animal Drugs: Cephalexin; Fentanyl; Milbemycin Oxime and Praziquantel", "Rule", "Final Rule", "2012-08-09T04:00:00Z", 2012, 8, "2012-08-09T04:00:00Z", null, "2012-08-09T14:24:03Z", "2012-19498", 0, 0, "09000064810ca31f"], ["FDA-2012-N-0002-0023", "FDA", "FDA-2012-N-0002", "Freedom of Information Summary NADA 141-338 Milbemy Oxime and Praziquantel", "Supporting & Related Material", "Freedom of Information Summary", "2012-08-09T04:00:00Z", 2012, 8, null, null, "2012-08-09T14:54:21Z", null, 0, 0, "09000064810ca9df"], ["FDA-2012-N-0002-0022", "FDA", "FDA-2012-N-0002", "Freedom of Information Summary NADA 141-337 Fentanyl", "Supporting & Related Material", "Freedom of Information Summary", "2012-08-09T04:00:00Z", 2012, 8, null, null, "2012-08-09T14:45:49Z", null, 0, 0, "09000064810ca9d9"], ["FDA-2012-N-0002-0019", "FDA", "FDA-2012-N-0002", "New Animal Drugs; Change of Sponsor; Change of Sponsor Address: Azaperone; Miconazole, Polymyxin B, and Prednisolone Suspension", "Rule", "Final Rule", "2012-08-06T04:00:00Z", 2012, 8, "2012-08-05T04:00:00Z", null, "2012-08-06T20:47:47Z", "2012-19147", 0, 0, "09000064810c2dc4"], ["FDA-2012-N-0002-0017", "FDA", "FDA-2012-N-0002", "Freedom of Information Summary NADA 141-263 Maropitant", "Supporting & Related Material", "Freedom of Information Summary", "2012-07-03T04:00:00Z", 2012, 7, null, null, "2012-07-03T15:25:37Z", null, 0, 0, "0900006481077b27"], ["FDA-2012-N-0002-0016", "FDA", "FDA-2012-N-0002", "Implantation or Injectable Dosage Form New Animal Drugs: Maropitant; Tildipirosin", "Rule", "Final Rule", "2012-07-03T04:00:00Z", 2012, 7, "2012-07-03T04:00:00Z", null, "2012-07-03T13:20:47Z", "2012-16203", 0, 0, "0900006481077f54"], ["FDA-2012-N-0002-0018", "FDA", "FDA-2012-N-0002", "Freedom of Information Summary NADA 141-334 Tildipirosin", "Supporting & Related Material", "Freedom of Information Summary", "2012-07-03T04:00:00Z", 2012, 7, null, null, "2012-07-03T15:34:44Z", null, 0, 0, "0900006481077b2a"], ["FDA-2012-N-0002-0014", "FDA", "FDA-2012-N-0002", "Conditionally Approved New Animal Drugs for Minor Use and Minor Species Masitinib", "Rule", "Final Rule", "2012-06-15T04:00:00Z", 2012, 6, null, null, "2012-06-15T15:29:02Z", "2012-14635", 0, 0, "090000648104c52f"], ["FDA-2012-N-0002-0015", "FDA", "FDA-2012-N-0002", "Freedom of Information Summary CNADA 141 308 KINAVET CA1", "Other", "Freedom of Information Summary (No Federal Register Publication)", "2012-06-15T04:00:00Z", 2012, 6, "2012-06-15T04:00:00Z", null, "2024-11-12T05:04:56Z", null, 1, 0, "090000648104cd38"], ["FDA-2012-N-0002-0013", "FDA", "FDA-2012-N-0002", "New Animal Drugs: Change of Sponsor's Name", "Rule", "Final Rule", "2012-06-04T04:00:00Z", 2012, 6, "2012-06-04T04:00:00Z", null, "2012-06-05T13:11:11Z", "2012-13409", 0, 0, "0900006481031749"], ["FDA-2012-N-0002-0012", "FDA", "FDA-2012-N-0002", "New Animal Drugs Altrenogest Dexamethasone Florfenicol", "Rule", "Final Rule", "2012-05-31T04:00:00Z", 2012, 5, null, null, "2012-05-31T17:06:27Z", "2012-13095", 0, 0, "0900006481022d77"], ["FDA-2012-N-0002-0011", "FDA", "FDA-2012-N-0002", "New Animal Drugs; Changes of Sponsors: Estradiol; Estradiol Benzoate and Testosterone Propionate; Progesterone and Estradiol Benzoate; etc.", "Rule", "Final Rule", "2012-05-30T04:00:00Z", 2012, 5, "2012-05-30T04:00:00Z", null, "2012-05-30T16:01:07Z", "2012-13010", 0, 0, "09000064810215a5"], ["FDA-2012-N-0002-0010", "FDA", "FDA-2012-N-0002", "New Animal Drugs: Ceftiofur Sodium; Lincomycin Powder; Naracin; Tylosin", "Rule", "Final Rule", "2012-05-17T04:00:00Z", 2012, 5, null, null, "2012-05-17T13:34:00Z", "2012-11937", 0, 0, "090000648101233c"], ["FDA-2012-N-0002-0009", "FDA", "FDA-2012-N-0002", "Oral Dosage Form New Animal Drugs: Change of Sponsor; Griseofulvin Powder; Levamisole Hydrochloride Powder; Oxytetracycline Powder", "Rule", "Final Rule", "2012-05-14T04:00:00Z", 2012, 5, "2012-05-14T04:00:00Z", null, "2012-05-14T14:03:52Z", "2012-11382", 0, 0, "090000648100d835"], ["FDA-2012-N-0002-0008", "FDA", "FDA-2012-N-0002", "New Animal Drugs: Fomepizole; Change of Sponsor;Change of Sponsor Address; Change of Sponsor Name and Address", "Rule", "Final Rule", "2012-05-07T04:00:00Z", 2012, 5, "2012-05-07T04:00:00Z", null, "2012-05-07T13:22:04Z", "2012-10892", 0, 0, "0900006481006620"], ["FDA-2012-N-0002-0006", "FDA", "FDA-2012-N-0002", "Freedom of Information Summary NADA 141-209 Tylosin", "Supporting & Related Material", "Freedom of Information Summary", "2012-05-03T04:00:00Z", 2012, 5, null, null, "2012-05-03T16:25:46Z", null, 0, 0, "0900006481003fea"], ["FDA-2012-N-0002-0005", "FDA", "FDA-2012-N-0002", "New Animal Drugs: Ceftiofur Crystalline Free Acid; Gamithromycin; Tylosin", "Rule", "Final Rule", "2012-05-03T04:00:00Z", 2012, 5, null, null, "2012-05-03T14:20:44Z", "2012-10632", 0, 0, "090000648100430c"], ["FDA-2012-N-0002-0007", "FDA", "FDA-2012-N-0002", "Freedom of Information Summary ANADA 200-484 Tylosin", "Supporting & Related Material", "Reference (internal unless indicated)", "2012-05-03T04:00:00Z", 2012, 5, null, null, "2012-05-03T16:27:15Z", null, 0, 0, "0900006481003fdc"], ["FDA-2012-N-0002-0004", "FDA", "FDA-2012-N-0002", "New Animal Drugs for Use in Animal Feeds; Tiamulin", "Rule", "Final Rule", "2012-04-23T04:00:00Z", 2012, 4, "2012-04-23T04:00:00Z", null, "2012-04-23T13:14:03Z", "2012-09708", 0, 0, "0900006480ff6023"], ["FDA-2012-N-0002-0003", "FDA", "FDA-2012-N-0002", "New Animal Drugs for Use in Animal Feeds: Tiamulin", "Rule", "Final Rule", "2012-04-17T04:00:00Z", 2012, 4, "2012-04-17T04:00:00Z", null, "2012-04-17T16:22:04Z", "2012-09196", 0, 0, "0900006480ff2822"], ["FDA-2012-N-0002-0002", "FDA", "FDA-2012-N-0002", "Oral Dosage Form New Animal Drugs: Lincomycin Hydrochloride Soluble Powder; Penicillin G Potassium in Drinking Water; Tetracycline Powder; Change of Sponsor", "Rule", "Final Rule", "2012-04-09T04:00:00Z", 2012, 4, "2012-04-09T04:00:00Z", null, "2012-04-09T13:48:12Z", "2012-08322", 0, 0, "0900006480fec060"], ["FDA-2012-N-0002-0001", "FDA", "FDA-2012-N-0002", "New Animal Drugs for Minor Use and Minor Species; CFR Correction", "Rule", null, "2012-03-28T04:00:00Z", 2012, 3, "2012-03-28T04:00:00Z", null, "2012-03-28T17:35:51Z", "2012-07532", 0, 0, "0900006480fe2f3e"]], "truncated": false, "filtered_table_rows_count": 46, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2012-N-0002"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-0002", "results": [{"value": "FDA", "label": "FDA", "count": 46, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2012-N-0002", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-0002", "results": [{"value": "Rule", "label": "Rule", "count": 24, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-0002&document_type=Rule", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 21, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-0002&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-0002&document_type=Other", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-0002", "results": [{"value": 2012, "label": 2012, "count": 39, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-0002&posted_year=2012", "selected": false}, {"value": 2013, "label": 2013, "count": 7, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-0002&posted_year=2013", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-0002&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-0002&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-0002&_facet=posted_month"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-0002&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-0002&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-0002&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-0002&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-0002&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 889.0464820433408, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}